NEWS
To stay up-to-date, ensure you are signed up to our newsletter.
ABC News: National melanoma screening calls as hairdressers trained to detect suspicious spots
Click the link for details: https://www.abc.net.au/news/2024-06-19/hairdresser-melanoma-skin-cancer-health-newcastle/103988070 For further information and to register for the course: https://www.tafensw.edu.au/spot-a-spot
Participants needed for clinical research project
Study title: Anxiety in Oncology Populations Do you have a lived experience of cancer and are 18 year or older? Researchers at The University of Melbourne are interested in psychological factors that contribute to the development and maintenance of anxiety in those with a current or previous diagnosis of Cancer.
Vaccine boost for skin cancer
From the Advertiser, 4 June 2024. By Zoe Smith and Sue Dunlevy. Click on the image to view a larger version.

Sunburnt: A Memoir of Sun, Surf and Skin Cancer
AMRF has a long standing association with Melanoma Patients Australia and would like to share this information about the book ‘Sunburnt’ with our community. Anne Gately, a member of the Melanoma Patients Australia Consumer Advisory Group, is launching her book Sunburnt. A Memoir of Sun, Surf and Skin Cancer on
Local survivors hope Kate Middleton’s cancer confession will scare people into making their own health a priority
From 7NEWS Adelaide, 24 March 2024. https://www.facebook.com/7NEWSAdelaide/videos/1067388364352587/
Professor’s Amazing Guinea Pig Results
From the Advertiser, March 22 2024. Click on the image to view a larger version.
Professor Georgina Long AO and Professor Richard Scolyer AO awarded 2024 Australians of The Year for melanoma research
Professor Georgina Long AO and Professor Richard Scolyer AO are being awarded 2024 Australians of The Year for their research into melanoma. The awards are bringing more prominence to melanoma and more awareness amongst Australians, which can only be a good thing. We urge everyone to be more sun safe
New government subsidised treatment options for some melanoma patients
As of 1 February 2024, Australians with unresectable or metastatic melanoma will have a new treatment option subsidised by the Pharmaceutical Benefits Scheme (PBS) with Opdualag (nivolumab/relatlimab) becoming available to patients at a government-subsidised price. The treatment is a combination of immunotherapies designed to help the body fight melanoma and